Senior Lecturer at Saveetha Medical Collage and Research Institution, India
Author's Profile
Summary
Dr. Deepika B is an accomplished researcher in the field of Medical Biotechnology, specializing in cancer biology, nanotechnology, and translational medicine. With a strong foundation in molecular techniques, in vivo experimentation, and innovative therapeutic approaches, she brings over three years of rich research experience. Her work is distinguished by its interdisciplinary nature, combining nanomedicine with oncology to develop novel therapeutic solutions.
Educational Details
Dr. Deepika earned her Ph.D. in Medical Biotechnology (2021–2024) from Chettinad Academy of Research and Education, Tamil Nadu, India. Her doctoral research focused on evaluating the anticancer efficacy of nano-nutraceuticals. She also holds an M.Sc. in Medical Biotechnology (2018–2020) from the same institution, with a thesis on nano-kaempferol and its angiogenesis-inhibitory properties. She completed her B.Sc. in Biotechnology (2016–2018) from Valliammal College for Women, affiliated with the University of Madras. Additionally, she completed certified training in Animal Handling and Experimentation from TANUVAS and undertook an internship in Clinical Research at Deepam Hospitals, Chennai.
Professional Experience
Throughout her academic and research career, Dr. Deepika has worked extensively in cell culture, molecular biology, and animal models, including zebrafish embryos and Swiss albino mice. She has performed a wide range of experimental procedures such as DNA/RNA extraction, PCR, tumor induction, cytotoxicity assays, and drug efficacy analysis. Her expertise also includes photochemical characterization and nanomaterial synthesis. She has collaborated on numerous interdisciplinary projects and demonstrated leadership in mentoring and research management.
Research Interests
Her research is focused on cancer biology, nanotechnology-based drug delivery, wound healing, and biocompatibility studies. Dr. Deepika explores natural bioactive compounds and their nanoformulations for cancer therapy and has contributed to studies involving toxicity profiles, gene expression analysis, and therapeutic applications of nanomaterials in biomedical science.
Author Metrics
Dr. Deepika has authored 24 research publications in Scopus-indexed journals with a cumulative impact factor of 50.59, including several Q1-ranked journals. Her current h-index is 10 with over 210 citations. She is also listed in ORCID: https://orcid.org/0000-0003-4441-7863, highlighting her contributions to high-impact biomedical research.
Awards and Honors
Dr. Deepika holds two granted Indian patents: one on the nanoformulation of Passiflora incarnata leaf extract (Patent No. 437722) and another on titanium dioxide nanoparticles synthesized from potato peel extract (Patent No. 453713). Additionally, she received a copyright registration for her COVID-19 side-effects survey study. Her scientific excellence and contribution to biotechnology have earned her recognition in the academic community.
Publication Top Notes
1. Multiple Radiations and its Effect on Biological Systems – A Review on In Vitro and In Vivo Mechanisms
Authors: D. Balasubramanian, G. Agraharam, A. Girigoswami, K. Girigoswami
Journal: Annals of Medicine, 57(1), Article ID: 2486595
Year: 2025
Highlights: This comprehensive review outlines the biological impacts of multiple radiation exposures, focusing on cellular and systemic responses observed in both in vitro and in vivo models. It discusses oxidative stress, DNA damage, apoptosis, and radioprotective strategies.
2. Dual Mechanism of Amphiroa anceps: Antiangiogenic and Anticancer Effects in Skin Cancer
Authors: G. Janani, A. Girigoswami, B. Deepika, S. Udayakumar, D.J. Mercy, et al.
Journal: Chemistry & Biodiversity
DOI: e202500626
Year: 2025
Highlights: This study demonstrates that Amphiroa anceps exhibits dual functionality by inhibiting angiogenesis and exerting cytotoxic effects on skin cancer cells, offering potential for novel marine-derived anticancer therapies.
3. Inhibitory Effect of Nano-Formulated Extract of Passiflora incarnata on Dalton’s Lymphoma Ascites-Bearing Swiss Albino Mice
Authors: B. Deepika, G. Janani, D. Jessy Mercy, S. Udayakumar, A. Girigoswami, K. Girigoswami
Journal: Pharmaceutics, 17(2), Article 270
Year: 2025
Highlights: This in vivo study confirms the anticancer potential of nano-formulated Passiflora incarnata extract by significantly suppressing tumor growth in DLA-bearing mice, with improved safety and efficacy compared to traditional formulations.
Impact Factor: 4.9 | Q1 Journal
4. Preparation of Titanium Dioxide Nanoparticles from Solanum Tuberosum Peel Extract and its Applications
Authors: A. Girigoswami, B. Deepika, A.K. Pandurangan, K. Girigoswami
Journal: Artificial Cells, Nanomedicine, and Biotechnology, 52(1), pp. 59–68
Year: 2024
Highlights: A green synthesis approach is used to develop titanium dioxide nanoparticles from potato peel extracts, showcasing effective antibacterial, antioxidant, and photocatalytic properties.
Impact Factor: 5.8 | Q1 Journal
5. Peony-Shaped Zinc Oxide Nanoflower Synthesized via Hydrothermal Route Exhibits Promising Anticancer and Anti-Amyloid Activity
Authors: A. Girigoswami, B. Deepika, S. Udayakumar, G. Janani, D.J. Mercy, K. Girigoswami
Journal: BMC Pharmacology and Toxicology, 25(1), Article 101
Year: 2024
Highlights: This work introduces a novel zinc oxide nanoflower morphology synthesized via a hydrothermal method, exhibiting high efficiency in inhibiting both cancer cell proliferation and amyloid aggregation.
Impact Factor: Q2 Journal
Conclusion
Dr. Balasubramanian Deepika presents a strong and competitive case for the Best Paper Award. Her cutting-edge contributions to nanomedicine and cancer biology, combined with solid publication metrics and patents, showcase her as a young scientist with the potential to drive significant future advancements. Minor improvements in international visibility and translational depth could place her research on a global innovation map.